The largest database of trusted experimental protocols

Hiv 1 p24 elisa kit

Manufactured by PerkinElmer
Sourced in United States, France

The HIV-1 p24 ELISA kit is a laboratory diagnostic tool used to detect the presence of the p24 antigen, a structural protein of the human immunodeficiency virus type 1 (HIV-1). The kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique to quantify the p24 antigen in biological samples, providing a means to monitor HIV-1 infection and disease progression.

Automatically generated - may contain errors

22 protocols using hiv 1 p24 elisa kit

1

Nanoparticle-Enhanced ELISA for p24 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NLFOA procedure was similar to that in the classical HIV-1 p24 ELISA (PerkinElmer, Waltham, MA, U.S.A.), except that Streptavidin (SA)-HRP and OPD (o-phenylenediamine dihydrochloride) were replaced with nanoparticle-streptavidin (Innova Biosciences, Cambridge, Cambs, U.K.), biotinylated TurboNuclease (bio-TurboNuclease) and the FLOS substrate (Fig 1). Bio-TurboNuclease was prepared using the ImmunoProbe Biotinylation Kit (Sigma Aldrich, Saint Louis, MO, U.S.A.). The 96-cell polystyrene microplate was coated with the p24 monoclonal antibody (from PerkinElmer HIV-1 p24 ELISA kit) and blocked with blocking buffer (PBS containing 5.0 g/L defatted milk powder). After p24 was added and the plate was incubated at 37°C for two hours, the biotinylated anti-p24 antibody (from PerkinElmer HIV-1 p24 ELISA kit) was added and incubated at 37°C for one hour. Nanoparticle-streptavidin was then added and incubated at 37°C for 40 minutes. After bio-TurboNuclease was added and incubated at 37°C for 40 minutes, FLOS in TurboNuclease reaction buffer (50 mM Tris-HCl, pH 8.0 and 1 mM MgCl2) was added and incubated at 37°C for 40 minutes. The fluorescence intensity was measured on a VICTOR X2 Series Multilabel Plate Reader (PerkinElmer, Waltham, MA, U.S.A.). A washing step with PBS containing 0.2% Tween 20 was performed between each step.
+ Open protocol
+ Expand
2

Production and Characterization of HIV Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant R5 HIV (HIVAD8) and X4 HIV (HIVNL4.3) were prepared by transfecting plasmid encoding full-length of each HIV gene (pAD8 [45 (link)] and pNL4.3 [46 (link)]) into HEK293T cells, respectively. A pseudotyped HIV-1 virus (HIVLuc-VSVG) expressing the luciferase gene (HIVLuc) was created by transfection of pHIV-1NL4/3-Luciferase-ΔEnv and p-VSV-G into HEK293T cells in 10 cm dishes [42 (link), 47 (link), 48 (link)]. The HIV-1NL4/3-EnvAD.8-ΔVpr with Vpr-BLAM was produced by transfection of pHIV-1NL4/3-EnvAD.8-ΔVpr and pVpr-BLAM [49 (link), 50 (link)] (a kind gift from Dr. Warner Greene) into HEK293T cells. All plasmid DNA transfections were conducted using TransIT-293 (Mirus, Houston, TX, USA) and Opti-MEM I medium (Thermo Fisher Scientific) following a method previously reported [42 (link)]. Supernatants were then ultracentrifuged at 100,000 × g for 2 hours at 4°C onto a 20% sucrose in 10 mM HEPES-150 mM NaCl cushion [51 (link)]. Pelleted particles were resuspended in D10 medium and the concentration of HIV p24 was quantitated by using an HIV-1 p24 ELISA Kit (Perkin Elmer, Boston, MA, USA) [44 (link), 51 (link)]. Infection titer (50% tissue culture infectious dose, TCID50) of each virus was determined by an endpoint assay [52 (link)].
+ Open protocol
+ Expand
3

Quantifying Jurkat Cell HIV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For untransfected Jurkat cells, HIV infection conditions were the same as for the M7-Lue cell line, but HIV infectivity was measured by HIV-1 p24 production at 7 days post infection using the HIV-1p24 ELISA kit (PerkinElmer). For CD44 or empty vector-transfected Jurkat cells, after 3 days of transfection, the cells were infected with 5 ng of HIV-p24 for 5 h, then washed three times with complete RPMI, resuspended in complete RPMI and cultured for 3 days. These cells were analyzed for HIV infection by two methods: first, by intracellular staining for HIV-p24 (KC-57RD1-PE; Beckman Coulter, Fullerton, CA, USA) and CD44 (anti-huCD44-APC; R&D system); and second, measuring HIV-1 p24 in the supernatant by p24 ELISA (PerkinElmer).
+ Open protocol
+ Expand
4

Production and Characterization of HIV Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant R5 HIV (HIVAD8) and X4 HIV (HIVNL4.3) were prepared by transfecting plasmid encoding full-length of each HIV gene (pAD8 [50 (link)] and pNL4.3 [51 (link)]) into HEK293T cells, respectively. A pseudotyped HIV-1 virus (HIVLuc-VSVG) expressing the luciferase gene (HIVLuc) was created by transfection of pHIV-1NL4/3-Luciferase-ΔEnv and p-VSV-G into HEK293T cells in 10 cm dishes [44 (link), 52 (link), 53 (link)]. The HIV-1NL4/3-EnvAD.8-ΔVpr with Vpr-BLAM was produced by transfection of pHIV-1NL4/3-EnvAD.8-ΔVpr and pVpr-BLAM [54 (link), 55 (link)] (a kind gift from Dr. Warner Greene) into HEK293T cells. All plasmid DNA transfections were conducted using TransIT-293 (Mirus, Houston, TX, USA) and Opti-MEM I medium (Thermo Fisher Scientific) following a method previously reported [44 (link)]. Supernatants were then ultracentrifuged at 100,000 x g for 2 hours at 4°C onto a 20% sucrose in 10 mM HEPES-150 mM NaCl cushion [56 (link)]. Pelleted particles were resuspended in D10 medium and the concentration of HIV p24 was quantitated by using an HIV-1 p24 ELISA Kit (Perkin Elmer, Boston, MA, USA) [49 (link), 56 (link)]. Infection titer (50% tissue culture infectious dose, TCID50) of each virus was determined by an endpoint assay [57 (link)].
+ Open protocol
+ Expand
5

Quantifying Glycosylation Effects on Viral Infectivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virus stocks were titrated in TZM-bl cells, and the TCID50 was calculated as discussed above. The p24 of the virus stock was determined by enzyme linked immunosorbent assay using HIV-1 p24 ELISA kit (PerkinElmer, USA). Equal amounts of CA-p24 (5 ng/mL) from untreated and glycosylation-modified viruses were used to infect TZM-bl cells for 48 h in the presence of 10 μg/mL DEAE-Dextran and RLUs calculated per nanogram of p24. All experiments were performed in triplicate.
+ Open protocol
+ Expand
6

Quantification of p24 Antigen in Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
p24 antigen in culture media was measured using the HIV-1 p24 ELISA Kit (Perkin Elmer). Absorbance was measured with a Synergy2 Biotek Microplate Reader (Winooski) using Gen5™ Reader Control and Data Analysis Software. The lower Limit of Detection of the assay was calculated as Mean + 2*Standard Deviation of the negative control (culture medium alone).
+ Open protocol
+ Expand
7

HIV Infection Assay with IL-2 Pretreatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2 or IL-2/IL27-pretreated CD4+ T cells were infected with HIVNL4.3 as previously described[2 (link)]. Half of the culture supernatants were replaced with fresh medium on day three. Viral replication was gauged from p24 levels in culture supernatants using an HIV-1 p24 ELISA kit (PerkinElmer). For single-round infection, CD4+ T cells were incubated with HIV-Luc-V (100 ng/ml p24) for 2 hours. Cells were washed and then cultured for 2 days in the presence of IL-2. Luciferase activity was measured with a Bright-Glo Luciferase Assay System (Promega).
+ Open protocol
+ Expand
8

HIV-1 p24 Gag ELISA Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the assessment of HIV-1 p24 Gag concentration in culture supernatants a commercially available HIV-1 p24 ELISA kit (Perkin Elmer) was used in accordance with the manufacturer’s instructions. Samples were read in duplicate on a TECAN Sunrise ELISA Plate Reader and analysed by Magellan Software Version 6.5. Analytical sensitivity of the ELISA was 4.3 pg/ml; reproducibility within the assay was C.V.: 5.5%.
+ Open protocol
+ Expand
9

Production and Characterization of HIV Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant R5 HIV (HIVAD8) and X4 HIV (HIVNL4.3) were prepared by transfecting plasmid encoding full-length of each HIV gene (pAD8 [50 (link)] and pNL4.3 [51 (link)]) into HEK293T cells, respectively. A pseudotyped HIV-1 virus (HIVLuc-VSVG) expressing the luciferase gene (HIVLuc) was created by transfection of pHIV-1NL4/3-Luciferase-ΔEnv and p-VSV-G into HEK293T cells in 10 cm dishes [44 (link), 52 (link), 53 (link)]. The HIV-1NL4/3-EnvAD.8-ΔVpr with Vpr-BLAM was produced by transfection of pHIV-1NL4/3-EnvAD.8-ΔVpr and pVpr-BLAM [54 (link), 55 (link)] (a kind gift from Dr. Warner Greene) into HEK293T cells. All plasmid DNA transfections were conducted using TransIT-293 (Mirus, Houston, TX, USA) and Opti-MEM I medium (Thermo Fisher Scientific) following a method previously reported [44 (link)]. Supernatants were then ultracentrifuged at 100,000 x g for 2 hours at 4°C onto a 20% sucrose in 10 mM HEPES-150 mM NaCl cushion [56 (link)]. Pelleted particles were resuspended in D10 medium and the concentration of HIV p24 was quantitated by using an HIV-1 p24 ELISA Kit (Perkin Elmer, Boston, MA, USA) [49 (link), 56 (link)]. Infection titer (50% tissue culture infectious dose, TCID50) of each virus was determined by an endpoint assay [57 (link)].
+ Open protocol
+ Expand
10

Cre-Flex Lentiviral Vector System

Check if the same lab product or an alternative is used in the 5 most similar protocols
A conditional LV system based on the Cre/loxP mechanism, here referred to as Cre-Flex (Cre-mediated FLip-EXcision) was designed as described previously (Fig 1)[23 (link)]. Briefly, the Cre-Flex LV vectors carry a CMV-driven reporter cassette encoding eGFP and Fluc flanked by two pairs of mutually exclusive lox sites. The reporter cassette is activated after Cre recombination. The Cre-Flex LV vectors were generated and produced by the Leuven Viral Vector Core at the KU Leuven, essentially as described previously [37 (link),38 (link)]. Viral titers were determined using p24 enzyme-linked immunosorbent assay (HIV-1 p24 ELISA kit, PerkinElmer, Milano, Italy) (unit: ng p24/mL).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!